BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28332874)

  • 1. LONG-TERM OUTCOME OF THE DIFFERENT TREATMENT ALTERNATIVES FOR RECURRENT AND PERSISTENT CUSHING DISEASE.
    Espinosa-de-Los-Monteros AL; Sosa-Eroza E; Espinosa E; Mendoza V; Arreola R; Mercado M
    Endocr Pract; 2017 Jul; 23(7):759-767. PubMed ID: 28332874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
    Geer EB; Shafiq I; Gordon MB; Bonert V; Ayala A; Swerdloff RS; Katznelson L; Lalazar Y; Manuylova E; Pulaski-Liebert KJ; Carmichael JD; Hannoush Z; Surampudi V; Broder MS; Cherepanov D; Eagan M; Lee J; Said Q; Neary MP; Biller BMK
    Endocr Pract; 2017 Aug; 23(8):962-970. PubMed ID: 28614003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
    Carroll TB; Javorsky BR; Findling JW
    Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosurgical Management of Patients With Persistent or Recurrent Cushing Disease After Prior Transsphenoidal Surgery: A Management Algorithm Based on a 25-Year Experience.
    Hughes JD; Young WF; Chang AY; Link MJ; Garces YI; Laack NN; Thompson GB; Pollock BE
    Neurosurgery; 2020 Apr; 86(4):557-564. PubMed ID: 31140563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of recurrent and refractory Cushing disease.
    Aghi MK
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):560-8. PubMed ID: 18711406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
    Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
    J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for Cushing disease after unsuccessful transsphenoidal surgery.
    Liu JK; Fleseriu M; Delashaw JB; Ciric IS; Couldwell WT
    Neurosurg Focus; 2007; 23(3):E8. PubMed ID: 17961031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of children treated for Cushing's disease: a single center experience.
    Yordanova G; Martin L; Afshar F; Sabin I; Alusi G; Plowman NP; Riddoch F; Evanson J; Matson M; Grossman AB; Akker SA; Monson JP; Drake WM; Savage MO; Storr HL
    Pituitary; 2016 Dec; 19(6):612-624. PubMed ID: 27678103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns in Cushing's disease patients in two large United States nationwide databases: application of a novel, graphical methodology.
    Broder MS; Neary MP; Chang E; Cherepanov D; Sun GH; Ludlam WH
    Pituitary; 2015 Aug; 18(4):474-9. PubMed ID: 25246076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing and predicting the Nelson-Salassa syndrome.
    Graffeo CS; Perry A; Carlstrom LP; Meyer FB; Atkinson JLD; Erickson D; Nippoldt TB; Young WF; Pollock BE; Van Gompel JJ
    J Neurosurg; 2017 Dec; 127(6):1277-1287. PubMed ID: 28084914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's disease: results of treatment and factors affecting outcome.
    Ammini AC; Bhattacharya S; Sahoo JP; Philip J; Tandon N; Goswami R; Jyotsna VJ; Khadgawat R; Chumber S; Seth A; Karak AK; Sharma BS; Chandra PS; Suri A; Sharma MS; Kale SS; Singh M
    Hormones (Athens); 2011; 10(3):222-9. PubMed ID: 22001133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E; Maiter D; Grandin C; Raftopoulos C
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options after surgical failure in Cushing's disease: A critical review.
    Rubinstein G; Osswald A; Zopp S; Ritzel K; Theodoropoulou M; Beuschlein F; Reincke M
    Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101270. PubMed ID: 31036383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
    Pouratian N; Prevedello DM; Jagannathan J; Lopes MB; Vance ML; Laws ER
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Cushing's disease: a single-center experience.
    Solak M; Kraljevic I; Dusek T; Melada A; Kavanagh MM; Peterkovic V; Ozretic D; Kastelan D
    Endocrine; 2016 Mar; 51(3):517-23. PubMed ID: 26215278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
    De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
    J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Patients with Nelson's Syndrome after Primary Treatment: A Multicenter Study from 13 UK Pituitary Centers.
    Fountas A; Lim ES; Drake WM; Powlson AS; Gurnell M; Martin NM; Seejore K; Murray RD; MacFarlane J; Ahluwalia R; Swords F; Ashraf M; Pal A; Chong Z; Freel M; Balafshan T; Purewal TS; Speak RG; Newell-Price J; Higham CE; Hussein Z; Baldeweg SE; Dales J; Reddy N; Levy MJ; Karavitaki N
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31735971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome in patients after treatment for Cushing's disease in childhood.
    Pasternak-Pietrzak K; MoszczyƄska E; Roszkowski M; Kot K; Marczak E; Grajkowska W; Pronicki M; Szalecki M
    PLoS One; 2019; 14(12):e0226033. PubMed ID: 31830115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
    Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
    J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.